We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Periodontal Disease Not a Likely Cause of Vascular Disease

By HospiMedica International staff writers
Posted on 01 May 2012
Healthy gums have not been proven to prevent atherosclerotic vascular disease (ASVD), nor will treating periodontal disease (PD) clearly reduce risk of heart attack or stroke, according to a new scientific statement.

The statement, released by the American Heart Association (AHA; Dallas, TX, USA), is the result of a systematic review by a group of cardiologists, dentists, and infectious disease specialists to assess whether available data support an independent association between ASVD and PD, and whether PD treatment might modify ASVD risks or outcomes. More...
The statement was endorsed by the American Dental Association (ADA, Chicago, IL, USA), and the World Heart Federation (Geneva, Switzerland).

The statement addresses concerns about possible links between PD and ASVD, which has recently intensified, driving an active field of investigation into possible association and causality, since the two disorders share several common risk factors, including smoking and diabetes mellitus (DM). As a result, both patients and providers are increasingly presented with claims that periodontal treatment strategies offer ASVD protection, claims that are often actively endorsed by professional and industrial stakeholders.

The researchers reviewed 537 studies on the topic, most observational in design. The studies did not provide consistent results on the impact of PD treatment on specific inflammatory markers, and failed to establish a durable benefit. They then discussed the correlation of PD with ASVD outcomes, as well as the correlation of response to PD therapy with ASVD event rates. The researchers found that the studies to date support an association between the two, independent of known confounders; they do not, however, support a causative relationship. The statement was published early online on April 18, 2012, in Circulation.

“Although a contribution of periodontal disease to atherosclerotic vascular disease is biologically plausible, periodontal and cardiovascular diseases share multiple risk factors that are prevalent and powerful promoters of disease, including tobacco use, diabetes mellitus, and age,” stated lead author Peter Lockhart, DDS. “Although periodontal interventions result in a reduction in systemic inflammation and endothelial dysfunction in short-term studies, there is no evidence that they prevent ASVD or modify its outcomes.”

Related Links:
American Heart Association
American Dental Association
World Heart Federation


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Digital Color Doppler Ultrasound System
MS22Plus
Pressure Guidewire
SavvyWire
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.